Literature DB >> 17364740

Albumin rescues ocular epithelial cells from cell death in dry eye.

Akihiro Higuchi1, Ryuji Ueno, Shigeto Shimmura, Makoto Suematsu, Murat Dogru, Kazuo Tsubota.   

Abstract

PURPOSE: Because autologous serum is useful for the treatment of severe dry eye, serum components may be a potential candidate for the treatment of dry eye. Serum albumin is abundantly contained in human serum and plays many physiologic roles. We investigated the efficacy of serum albumin in a dry eye animal model.
METHODS: Sprague-Dawley rats were used to make dry eye model rats according to a previous study. The central region of the corneal epithelium was scraped mechanically, and the rats were placed in a desiccation room (temperature, 23 +/- 2 degrees C; humidity, 28 +/- 2%; air flow, 2-4 m/s) for 12 hr. During desiccation, one eye of each rat was treated with human serum albumin eye drops, and the other eye was given a drop of phosphate buffered saline (PBS). Human corneal and conjunctival cell lines were used to investigate suppression effect of albumin on apoptosis induced by addition of apoptosis inducers or serum deprivation, respectively.
RESULTS: The erosion area was increased by 12 hr of desiccation. Albumin treatment decreased the area of erosion compared with PBS treatment. Apoptosis suppression assay using cell lines revealed that caspase-3 activation induced by serum deprivation and DNA fragmentation induced by addition of apoptosis inducers were dose-dependently suppressed by albumin.
CONCLUSIONS: Albumin showed a therapeutic effect in dry eye model rats. This efficacy may be related to the suppression of apoptosis by albumin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17364740     DOI: 10.1080/02713680601147690

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  12 in total

Review 1.  [Albumin eye drops for treatment of ocular surface diseases].

Authors:  J D Unterlauft; M Kohlhaas; I Hofbauer; K Kasper; G Geerling
Journal:  Ophthalmologe       Date:  2009-10       Impact factor: 1.059

Review 2.  TFOS DEWS II Tear Film Report.

Authors:  Mark D P Willcox; Pablo Argüeso; Georgi A Georgiev; Juha M Holopainen; Gordon W Laurie; Tom J Millar; Eric B Papas; Jannick P Rolland; Tannin A Schmidt; Ulrike Stahl; Tatiana Suarez; Lakshman N Subbaraman; Omür Ö Uçakhan; Lyndon Jones
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

Review 3.  Dysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatment.

Authors:  Mark S Milner; Kenneth A Beckman; Jodi I Luchs; Quentin B Allen; Richard M Awdeh; John Berdahl; Thomas S Boland; Carlos Buznego; Joseph P Gira; Damien F Goldberg; David Goldman; Raj K Goyal; Mitchell A Jackson; James Katz; Terry Kim; Parag A Majmudar; Ranjan P Malhotra; Marguerite B McDonald; Rajesh K Rajpal; Tal Raviv; Sheri Rowen; Neda Shamie; Jonathan D Solomon; Karl Stonecipher; Shachar Tauber; William Trattler; Keith A Walter; George O Waring; Robert J Weinstock; William F Wiley; Elizabeth Yeu
Journal:  Curr Opin Ophthalmol       Date:  2017-01       Impact factor: 3.761

4.  Human albumin eye drops as a therapeutic option for the management of keratoconjunctivitis sicca secondary to chronic graft-versus-host disease after stem-cell allografting.

Authors:  J T Seki; N Sakurai; S Moldenhauer; J Dam; E G Atenafu; P M Yip; T Mazzulli; T Henderson; J Pendergrast; C Cserti; J P Velazquez; R Simpson; G Felluga; H A Messner; J H Lipton
Journal:  Curr Oncol       Date:  2015-10       Impact factor: 3.677

Review 5.  Epithelial-immune cell interaction in dry eye.

Authors:  Stephen C Pflugfelder; Cintia S de Paiva; De-Quan Li; Michael E Stern
Journal:  Cornea       Date:  2008-09       Impact factor: 2.651

6.  Selenoprotein P controls oxidative stress in cornea.

Authors:  Akihiro Higuchi; Kazuhiko Takahashi; Masaki Hirashima; Tetsuya Kawakita; Kazuo Tsubota
Journal:  PLoS One       Date:  2010-03-29       Impact factor: 3.240

Review 7.  [Autologous serum and alternative blood products for the treatment of ocular surface disorders].

Authors:  G Geerling; J D Unterlauft; K Kasper; S Schrader; A Opitz; D Hartwig
Journal:  Ophthalmologe       Date:  2008-07       Impact factor: 1.059

8.  A mouse dry eye model induced by topical administration of benzalkonium chloride.

Authors:  Zhirong Lin; Xiaochen Liu; Tong Zhou; Yihui Wang; Li Bai; Hui He; Zuguo Liu
Journal:  Mol Vis       Date:  2011-01-25       Impact factor: 2.367

9.  Solvent/Detergent Virally Inactivated Serum Eye Drops Restore Healthy Ocular Epithelium in a Rabbit Model of Dry-Eye Syndrome.

Authors:  Ching-Li Tseng; Zhi-Yu Chen; Ting-Yi Renn; Shun-Hung Hsiao; Thierry Burnouf
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

10.  The effects of PEP-1-FK506BP on dry eye disease in a rat model.

Authors:  Dae Won Kim; Sung Ho Lee; Sae Kwang Ku; Ji Eun Lee; Hyun Ju Cha; Jong Kyu Youn; Hyeok Yil Kwon; Jong Hoon Park; Eun Young Park; Sung-Woo Cho; Kyu Hyung Han; Jinseu Park; Won Sik Eum; Soo Young Choi
Journal:  BMB Rep       Date:  2015-03       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.